Definitive Contract 75N93021C00064
Award Date 9/1/21
Potential Completion Date 8/31/22
Potential Value $295K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
College Station, TX, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This $299,584 firm fixed price contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Inbios International Inc. of Seattle, Washington to develop the Next-Gen Chagas DetectTM Plus rapid test for sensitive and specific diagnosis of Chagas disease. The contract is being performed under Phase I of the Small Business Innovation Research program in response to a solicitation seeking proposals for innovative solutions in infectious disease...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Ai Biosciences, Inc., a minority-owned and self-certified small disadvantaged business located in College Station, Texas. The $300,000.00 Firm Fixed Price contract is for the development of a rapid reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay to enable self-monitoring of acute or rebound HIV-1 infection using a finger-prick...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Kephera Diagnostics LLC, a for-profit limited liability company, to develop a biomarker-based test of cure (TOC) to evaluate treatment outcome during the chronic phase of Chagas infection. The contract, a Definitive Contract with Firm Fixed Price pricing, has a potential value of $300,000.00 and a...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Darwin Biosciences, Inc., a minority-owned, woman-owned small business based in Broomfield, Colorado. The $299,408 firm-fixed-price contract is for the development of rapid diagnostic assays to aid in the self-monitoring of acute or rebound HIV-1 infection. The contract has an ultimate completion date of April 14, 2025. As an SBIR Phase I award,...
- This is a federal contract award to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $299,997.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for the development of a Rapid Point-of-Care HIV Viral Load Test, which aligns with NIAID's mission to conduct and...
- This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
- This SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) to Intuitive Biosciences Inc. for $299,855. The contract is associated with the NIH and Centers for Disease Control and Prevention (CDC) SBIR solicitation seeking proposals across numerous technical topics to advance public health goals through medical technologies, diagnostics, vaccines, cell therapies and other...
- This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type. The contract is for the development of an "easy-to-use, low-cost triplex RDT for the...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $306,206.00 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract to Intuitive Biosciences Inc., a small disadvantaged business, to develop "THE EV-HIV ASSAY, A POINT-OF-CARE LATERAL FLOW IMMUNOASSAY TO ACCURATELY IDENTIFY HIV INFECTION FROM BLOOD-BASED EXTRACELLULAR VESICLES." This contract is linked to a broader SBIR solicitation issued by the NIAID and Centers for Disease Control...
- This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...